help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sakai, K.
Right arrow Articles by Suda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sakai, K.
Right arrow Articles by Suda, T.

Endocrinology, Vol 137, 1758-1763, Copyright © 1996 by Endocrine Society


ARTICLES

Regulation of corticotropin-releasing factor receptor messenger ribonucleic acid in rat anterior pituitary

K Sakai, N Horiba, Y Sakai, F Tozawa, H Demura and T Suda
Department of Medicine, Hirosaki University School of Medicine, Japan.

Adrenalectomy (ADX) leads to a decrease in the number of CRF-binding sites in the rat anterior pituitary (AP). However, the molecular mechanisms of CRF receptor (CRF-R) regulation are unknown. In the present study, we analyzed the effects of ADX on pituitary CRF-R1 messenger RNA (mRNA) levels in vivo and the direct effects of CRF, arginine vasopressin (AVP), and glucocorticoid, the levels of which are altered by ADX, on CRF-R1 mRNA levels in vitro. The mRNA level was determined by Northern blot analysis using a rat brain CRF-R1 complementary RNA probe. The CRF-R1 level in AP fell to 20% of the sham level 1 day after ADX and returned to the sham level after 14 days. In cultured rat AP cells, treatment with CRF, AVP, and dexamethasone led to significant reductions in CRF-R1 mRNA, with maximal inhibition to 32%, 22%, and 37% of control levels, respectively. The time course of CRF-R1 mRNA reduction varied depending on the drug, with effects detectable as early as 1 h after treatment. These findings indicate that elevated portal CRF and AVP levels may contribute to the decrease in CRF-R1 mRNA soon after ADX. A decrease in mRNA levels, in turn, may lead to a decrease in CRF-R1 protein on corticotrophs.


This article has been cited by other articles:


Home page
EndocrinologyHome page
K. Kageyama, K. Hanada, T. Moriyama, T. Nigawara, S. Sakihara, and T. Suda
G Protein-Coupled Receptor Kinase 2 Involvement in Desensitization of Corticotropin-Releasing Factor (CRF) Receptor Type 1 by CRF in Murine Corticotrophs
Endocrinology, January 1, 2006; 147(1): 441 - 450.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kageyama, C. Li, and W. W. Vale
Corticotropin-Releasing Factor Receptor Type 2 Messenger Ribonucleic Acid in Rat Pituitary: Localization and Regulation by Immune Challenge, Restraint Stress, and Glucocorticoids
Endocrinology, April 1, 2003; 144(4): 1524 - 1532.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. A. Nolan and A. Levy
Temporally Sensitive Trophic Responsiveness of the Adrenalectomized Rat Anterior Pituitary to Dexamethasone Challenge: Relationship between Mitotic Activity and Apoptotic Sensitivity
Endocrinology, January 1, 2003; 144(1): 212 - 219.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. C. Coste, K. A. Heldwein, S. L. Stevens, E. Tobar-Dupres, and M. P. Stenzel-Poore
IL-1{alpha} and TNF{alpha} Down-Regulate CRH Receptor-2 mRNA Expression in the Mouse Heart
Endocrinology, August 1, 2001; 142(8): 3537 - 3545.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. Nomura, Y. Iwasaki, M. Saito, Y. Aoki, E. Yamamori, N. Ozaki, K. Tachikawa, N. Mutsuga, M. Morishita, M. Yoshida, et al.
Involvement of upstream open reading frames in regulation of rat V1b vasopressin receptor expression
Am J Physiol Endocrinol Metab, May 1, 2001; 280(5): E780 - E787.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
K. Kageyama, G. E. Gaudriault, M. J. Bradbury, and W. W. Vale
Regulation of Corticotropin-Releasing Factor Receptor Type 2{beta} Messenger Ribonucleic Acid in the Rat Cardiovascular System by Urocortin, Glucocorticoids, and Cytokines
Endocrinology, July 1, 2000; 141(7): 2285 - 2293.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. A. Myers, M. E. Bell, T. J. McDonald, and T. R. Myers
Corticotropin-Releasing Factor Receptor Expression in the Pituitary of Fetal Sheep after Lesion of the Hypothalamic Paraventricular Nucleus
Endocrinology, September 1, 1999; 140(9): 4292 - 4299.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
O. Marti, R. Andres, and A. Armario
Defective ACTH response to stress in previously stressed rats: dependence on glucocorticoid status
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 1999; 277(3): R869 - R877.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. L. M. Dahia and A. B. Grossman
The Molecular Pathogenesis of Corticotroph Tumors
Endocr. Rev., April 1, 1999; 20(2): 136 - 155.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
S. J. McClennen, D. N. Cortright, and A. F. Seasholtz
Regulation of Pituitary Corticotropin-Releasing Hormone-Binding Protein Messenger Ribonucleic Acid Levels by Restraint Stress and Adrenalectomy
Endocrinology, November 1, 1998; 139(11): 4435 - 4441.
[Abstract] [Full Text] [PDF]


Home page
J. Neurosci.Home page
I. Dijkstra, F. J. H. Tilders, G. Aguilera, A. Kiss, C. Rabadan-Diehl, N. Barden, S. Karanth, F. Holsboer, and J. M. H. M. Reul
Reduced Activity of Hypothalamic Corticotropin-Releasing Hormone Neurons in Transgenic Mice with Impaired Glucocorticoid Receptor Function
J. Neurosci., May 15, 1998; 18(10): 3909 - 3918.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
P. A. Iredale and R. S. Duman
Glucocorticoid Regulation of Corticotropin-Releasing Factor1 Receptor Expression in Pituitary-Derived AtT-20 Cells
Mol. Pharmacol., May 1, 1997; 51(5): 794 - 799.
[Abstract] [Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
Y. Sakai, N. Horiba, K. Sakai, F. Tozawa, A. Kuwayama, H. Demura, and T. Suda
Corticotropin-Releasing Factor Up-Regulates Its Own Receptor Gene Expression in Corticotropic Adenoma Cells in Vitro
J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1229 - 1234.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1996 by The Endocrine Society